Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy

BACKGROUND: People with HIV (PWH) on antiretroviral therapy (ART) still experience an increased risk of morbidity and mortality, presumably driven by chronic inflammation, yet predictors of discrete or combinatorial outcomes remain unclear. Galectin-9 (Gal-9), a driver of both inflammatory and immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Premeaux, Thomas A., Moser, Carlee B., McKhann, Ashley, Hoenigl, Martin, Laws, Elizabeth I., Aquino, Draven L., Lederman, Michael M., Landay, Alan L., Gianella, Sara, Ndhlovu, Lishomwa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Science: Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631144/
https://www.ncbi.nlm.nih.gov/pubmed/34366381
http://dx.doi.org/10.1097/QAD.0000000000003048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631144/
https://www.ncbi.nlm.nih.gov/pubmed/34366381
http://dx.doi.org/10.1097/QAD.0000000000003048

Ejemplares similares